Embecta names Nimish Muzumdar SVP, President North America

Embecta Corporation

Embecta Corporation

EMBC

0.00
  • Embecta named Nimish Muzumdar senior vice president, president of North America, effective June 15, 2026.
  • He will run U.S., Canada commercial teams, execute the region’s long-term growth strategy, report to CEO Dev Kurdikar.
  • Muzumdar was SVP, head of generics at Sandoz, leading retail, institutional, hospitals, clinics channels for a $1 billion division.
  • Earlier roles included leadership posts in generics oncology, injectables, retail generics at Sandoz; marketing roles at Ranbaxy USA, Watson, Dr. Reddy’s.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Embecta Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606160630PRIMZONEFULLFEED9747400) on June 16, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.